Clinical Applications of FelixFiller®
FelixFiller® product line is designed to meet various aesthetic needs by addressing different skin layers and facial structures.
Each formulation is optimized based on injection depth, tissue interaction and targeted correction area, ensuring maximum performance and safety in professional practice. FelixFiller® products are developed for different injection depths and facial indications, offering controlled, safe and predictable results for medical aesthetic professionals.
It provides a smooth texture and natural integration with the upper dermis, making it suitable for fine aesthetic details.
- Fine wrinkles
- Perioral lines
- Lip contour definition
- Skin hydration enhancement
- Upper dermal applications
- Injection Layer: Upper Dermis
- HA Concentration: 20 mg/ml
- Structure: Cross-linked Hyaluronic Acid
- Indication Area: Superficial aesthetic corrections
Superficial Dermal Applications
FelixFiller® Fine
Its balanced viscosity allows smooth injection and stable support for medium-depth aesthetic corrections.
- Nasolabial folds
- Marionette lines
- Mid-face volume restoration
- Facial contour shaping
- Deep dermal injection applications
- Injection Layer: Deep Dermis
- HA Concentration: 20 mg/ml
- Structure: Cross-linked Hyaluronic Acid
- Indication Area: Mid-dermal volume correction
Mid-Dermal Volume and Contour
FelixFiller® Deep
It provides long-lasting volume support in subcutaneous and periosteal applications where structural integrity is required.
- Jawline contouring
- Chin augmentation
- Facial structural volume restoration
- Support for advanced lifting procedures
- Subcutaneous and supraperiosteal applications
- Injection Layer: Subcutaneous / Periosteal
- HA Concentration: 20 mg/ml
- Structure: Cross-linked Hyaluronic Acid
- Indication Area: Deep structural volume
Deep Structural Volume Applications
FelixFiller® Sub Q
All FelixFiller® products are intended for professional use by qualified medical aesthetic practitioners. Proper training and anatomical knowledge are required for safe and effective application of dermal filler products.
Test Reports
| # | Test Name | Description | Document |
|---|---|---|---|
| 1 | FLXF - Cytotoxicity Test EN (M1532) | Evaluation of potential cytotoxic effects on living cells according to ISO 10993 standards. | Download PDF |
| 2 | FLXF - Deri Sensitizasyon Testi (M1532) | Assessment of allergic skin reaction potential of the product. | Download PDF |
| 3 | FLXF - Genotoksisite Testi (İn vitro Mikronükleus) (M1532) | In vitro genetic damage evaluation using micronucleus assay. | Download PDF |
| 4 | FLXF - Genotoksisite Testi (Mutasyon) (M1532) | Investigation of mutagenic potential in cellular genetic material. | Download PDF |
| 5 | FLXF - Genotoxicity Test (In vitro Micronucleus) EN (M1532) | English version of the in vitro genotoxicity micronucleus test report. | Download PDF |
| 6 | FLXF - Genotoxicity Test (Mutation) EN (M1532) | English mutation genotoxicity analysis according to international standards. | Download PDF |
| 7 | FLXF - İrritasyon Testi (M1532) | Skin irritation and local tolerance evaluation. | Download PDF |
| 8 | FLXF - Irritation Test EN (M1532) | English report of skin irritation assessment. | Download PDF |
| 9 | FLXF - Pirojenite Testi (M1532) | Evaluation of pyrogenic activity to detect fever-causing substances. | Download PDF |
| 10 | FLXF - Pyrogenicity Test EN (M1532) | English version of pyrogenicity safety evaluation report. | Download PDF |
| 11 | FLXF - Sitotoksisite Testi (M1532) | Secondary cytotoxic evaluation based on extended biocompatibility study. | Download PDF |
| 12 | FLXF - Skin Sensitization Test EN (M1532) | English version of skin sensitization risk assessment. | Download PDF |
| 13 | FLXF - Stabilite Testi (2 Yıllık) (M1532) | Two-year stability and shelf-life performance evaluation. | Download PDF |
| 14 | FLXF - Stabilite Testi (5 Yıllık) (M1532) | Five-year product stability and durability assessment. | Download PDF |
| 15 | FLXF - Subacute Systemic Toxicity EN (M1532) | Evaluation of short-term systemic toxicity via repeated exposure. | Download PDF |
| 16 | FLXF - Subakut Sistemik Toksisite (M1532) | Short-term systemic toxicity analysis (Turkish report). | Download PDF |
| 17 | FLXF - Subchronic Systemic Toxicity EN (M1532) | Evaluation of mid-term systemic exposure effects. | Download PDF |
| 18 | FLXF - Subkronik Sistemik Toksisite (M1532) | Medium-term systemic toxicity evaluation (Turkish version). | Download PDF |
Clinical Applications – Frequently Asked Questions
This section provides answers to the most common clinical questions about FelixFiller® products, including their indications, application techniques, safety profile and product specifications.
All FelixFiller® products are intended for use by licensed medical professionals. For detailed clinical documentation, training or technical support, please contact our professional service team.
FelixFiller® is a cross-linked hyaluronic acid dermal filler system developed for professional aesthetic procedures such as wrinkle correction, volume restoration and facial contouring.It is intended for use only by licensed medical professionals.
FelixFiller® is used for:
- Correction of facial wrinkles and folds
- Nasolabial fold and marionette line treatment
- Lip contouring and volume enhancement
- Mid-face and cheek volume restoration
- Jawline and chin contouring
- General facial volume loss due to aging
- FelixFiller® Fine: For superficial lines and fine wrinkles in the upper dermis
- FelixFiller® Deep: For moderate to deep wrinkles and mid-dermal volume restoration
- FelixFiller® Sub Q: For deep structural applications such as jawline and chin volume
The duration of effect depends on the product used, treated area, injection depth and patient-specific factors.
On average, results last between 6 and 18 months.
FelixFiller® is designed to be biocompatible with human tissue. However, for patients with highly sensitive skin or allergy history, a medical evaluation is recommended before treatment.
Yes. FelixFiller® formulations contain lidocaine to improve patient comfort and help reduce pain during injection.
FelixFiller® should not be used in:
- Patients with known hypersensitivity to hyaluronic acid or lidocaine
- Pregnant or breastfeeding women
- Patients with active skin infections or inflammation in the treatment area
- Individuals with severe allergies or autoimmune diseases
- Patients under 18 years of age
Common, usually mild and temporary side effects may include:
- Redness
- Swelling
- Tenderness
- Bruising at the injection site
Yes. As a hyaluronic acid filler, FelixFiller® can be dissolved using hyaluronidase in case of undesired results or complications, allowing additional safety and control.
FelixFiller® should be stored:
- Between +2°C and +25°C
- Away from direct sunlight and heat sources
- In a dry, clean environment
- Without freezing